Navigation Links
High-flux hemodialysis prolongs survival in many patients with CKD
Date:2/20/2009

High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN). The results suggest that this procedure could be beneficial for those with poor prognoses and those with diabetes.

In patients with CKD, toxins accumulate in the blood because the kidneys lose their ability to eliminate these substances sufficiently. CKD patients undergo either high-flux or low-flux hemodialysis to clear these toxins from the body (high-flux membranes have larger pores that allow for the removal of toxins of greater molecular size). While epidemiological studies have indicated that treatment with high-flux hemodialysis improved survival, the true potential of this treatment on prolonging life has not been clearly determined.

Francesco Locatelli, MD (A. Manzoni Hospital, Lecco, Italy), and his colleagues in eight European countries conducted a clinical trial to investigate the effect of high-flux hemodialysis on patient survival. In a randomized clinical trial called the Membrane Permeability Outcome (MPO) study, they enrolled 738 hemodialysis patients and assigned them to either low-flux or high-flux hemodialysis. Patients were followed for 3 to 7.5 years; in the entire study group the researchers did not detect a significant survival benefit with either high-flux or low-flux hemodialysis, but the use of high-flux membranes conferred a significant survival benefit in higher-risk patients. In addition, patients with diabetes showed a survival benefit with high-flux dialysis.

These findings could lead to potentially valuable clinical benefits for patients with CKD. However, because the benefits in diabetic patients were found only after a post-hoc analysis of the data, Dr. Locatelli's team noted that their results in diabetic patients need to be confirmed by other clinical trials.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology
Source:Eurekalert  

Related medicine news :

1. First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary
2. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
3. Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award
4. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
5. Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
6. Radiation therapy prolongs life in men with recurrent prostate cancer
7. Golf prolongs life
8. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
9. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
10. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
11. 2 gene mutations linked to most common brain cancers -- and longer survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High-flux hemodialysis prolongs survival in many patients with CKD
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon Dr. ... the official journal of The American Society for Aesthetic Plastic Surgery, in which ... is designed to correct drooping, retracted lower eyelids, which usually result from genetics, ...
(Date:1/16/2017)... ... ... NexTec Group has been selected as a member of the Bob Scott’s VAR ... field of midmarket financial software. , Members of the VAR Stars were selected based ... on revenue and those firms chosen represent a wide range of size and many ...
(Date:1/15/2017)... California (PRWEB) , ... January 15, 2017 , ... "On ... stylistic slideshow with complete customization and ease," said Christina Austin - CEO of Pixel ... controls so that users can edit the style and animation of their slideshows. Place ...
(Date:1/14/2017)... (PRWEB) , ... January 14, 2017 , ... ... the distinctions among their expanding line of activated charcoal products. With more and ... importance of categorizing their products according to how they cater to specific needs. ...
(Date:1/13/2017)... ... 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer will ... This Congress is expertly designed to meet the educational needs of European oncology ... , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... 2017 On Thursday, January 12, ... and the S&P 500 edged lower at the closing ... session in bearish territories. Taking into consideration yesterday,s market ... morning: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Holdings Inc. (NASDAQ: INCR ), and La ...
(Date:1/13/2017)...  Secretary of Health Karen Murphy today ... at Misericordia University and discussed the Wolf Administration,s efforts ... . "The opioid epidemic is the ... my professional career," Secretary Murphy said. "This area of ... by heroin and prescription opioid overdoses. Across the commonwealth ...
(Date:1/13/2017)... , Jan. 13, 2017 Concord Medical Services ... CCM ), a leading specialty hospital management solution ... and diagnostic imaging centers in China ... fund with Zhongrong International Trust Co., Ltd. ("ZRT"). ... to set up Zhongrong Taihe Healthcare Fund in October ...
Breaking Medicine Technology: